Reaction
Blood Immunoglobulin M Increased reporting signals
As of the last recalculation, Blood Immunoglobulin M Increased appears in 604 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ICOSAPENT ETHYL (PRR 136.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Icosapent Ethyl | 32 | 136.7 | 137.2 |
| Calcium Gluconate | 30 | 90.2 | 90.4 |
| Ibrutinib | 130 | 70.4 | 70.5 |
| Desoximetasone | 32 | 61.1 | 61.2 |
| Moxifloxacin Hydrochloride | 31 | 55.5 | 55.6 |
| Rosuvastatin Calcium | 31 | 39.9 | 40.0 |
| Olmesartan Medoxomil | 33 | 33.4 | 33.4 |
| Carfilzomib | 14 | 17.4 | 17.4 |
| Bendamustine Hcl | 7 | 15.7 | 15.7 |
| Voclosporin | 3 | 12.0 | 12.0 |
| Daratumumab | 12 | 10.5 | 10.5 |
| Certolizumab Pegol | 33 | 10.2 | 10.2 |
| Ixazomib | 7 | 8.5 | 8.5 |
| Pomalidomide | 19 | 6.5 | 6.5 |